Annual Current Ratio
23.29
+16.88+263.34%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual current ratio is 23.29, with the most recent change of +16.88 (+263.34%) on December 31, 2023.
- During the last 3 years, CTNM annual current ratio has risen by +4.30 (+22.64%).
- CTNM annual current ratio is now at all-time high.
Performance
CTNM Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
37.06
-21.86-37.10%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly current ratio is 37.06, with the most recent change of -21.86 (-37.10%) on September 30, 2024.
- Over the past year, CTNM quarterly current ratio has increased by +13.77 (+59.12%).
- CTNM quarterly current ratio is now -37.10% below its all-time high of 58.92, reached on June 30, 2024.
Performance
CTNM Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
CTNM Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +263.3% | +59.1% |
| 3 y3 years | +22.6% | +478.2% |
| 5 y5 years | +22.6% | +478.2% |
CTNM Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +263.3% | -37.1% | +478.2% |
| 5 y | 5-year | at high | +263.3% | -37.1% | +478.2% |
| alltime | all time | at high | +263.3% | -37.1% | +478.2% |
Contineum Therapeutics Class A Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 37.06(-37.1%) |
| Jun 2024 | - | 58.92(+206.9%) |
| Mar 2024 | - | 19.20(-17.6%) |
| Dec 2023 | 23.29 | 23.29(+25.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | 18.50(+188.6%) |
| Dec 2022 | 6.41(-66.2%) | - |
| Dec 2022 | - | 6.41 |
| Dec 2021 | 18.99 | - |
FAQ
- What is Contineum Therapeutics Class A annual current ratio?
- What is the all time high annual current ratio for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual current ratio year-on-year change?
- What is Contineum Therapeutics Class A quarterly current ratio?
- What is the all time high quarterly current ratio for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly current ratio year-on-year change?
What is Contineum Therapeutics Class A annual current ratio?
The current annual current ratio of CTNM is 23.29
What is the all time high annual current ratio for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual current ratio is 23.29
What is Contineum Therapeutics Class A annual current ratio year-on-year change?
Over the past year, CTNM annual current ratio has changed by +16.88 (+263.34%)
What is Contineum Therapeutics Class A quarterly current ratio?
The current quarterly current ratio of CTNM is 37.06
What is the all time high quarterly current ratio for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly current ratio is 58.92
What is Contineum Therapeutics Class A quarterly current ratio year-on-year change?
Over the past year, CTNM quarterly current ratio has changed by +13.77 (+59.12%)